The contribution of patient associations in clinical trials

2022-10-05T11:20:42+00:00September 28th, 2022|Categories: Medical Research, Meditrial|

Historically, patient organizations have had the primary purpose of supporting the communities they represented. Today, this remains a crucial function, but modes have changed, as has the role that associations and patients themselves take on in clinical research. The WHO [...]

The importance of the Data Monitoring Committee in the trials of today and tomorrow

2022-09-28T11:02:03+00:00September 21st, 2022|Categories: Medical Research, Meditrial|

Dr. Paola Antonini, Meditrial Scientific Director All clinical trials benefit from oversight, which is currently provided by regulatory authorities, Ethics Committees or Institutional Review Boards, and Data Monitoring Committees (Dmc), also sometimes referred to as Data Safety Monitoring [...]

Early feasibility studies on devices: “doing it sooner” to avoid trial failure

2022-09-28T10:21:58+00:00September 15th, 2022|Categories: Medical Research, Meditrial|

Paola Antonini, Meditrial Scientific Director. It is estimated that more than 90% of clinical trials fail due to limited patient recruitment, investigator inefficiencies, insufficient understanding of local ethical and regulatory aspects, site and region selected for conducting the [...]

SaMD, artificial intelligence and machine learning: regulators’ first steps

2022-09-16T16:01:49+00:00September 7th, 2022|Categories: Medical Research, Meditrial|

Dr.ssa Paola Antonini, Meditrial scientific director The International medical device regulators forum (Imdrf), describes Software as a Medical Device (SaMD) as software that can run on generic (non-medical) computing platforms. They can be used in conjunction with other [...]


2022-08-04T13:43:59+00:00July 20th, 2022|Categories: Medical Research, Meditrial|Tags: , , , , , , , |

When novel drugs or medical devices are evaluated in clinical trials, the data generated in this process is called clinical data. Improving the use of technology in clinical trials is now a prime opportunity for the life sciences industry. [...]

Go to Top